AIM
BCLI

Acrospire Investment Management’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Acrospire Investment Management’s Portfolio BCLI Stock Details BCLI Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-407
Closed -$25K – 158
2017
Q2 		$25K Buy
407
+168
+70% +$10.3K 0.02% 1392
2017
Q1 		$15K Sell
239
-41
-15% -$2.57K 0.01% 1730
2016
Q4 		$11K Buy
+280
New +$11K ﹤0.01% 1925